GPT and COVID-19: Elevations of circulating markers of liver injury in the context of COVID-19, particularly serum aspartate transaminase (AST) and alanine transaminase (ALT), are associated with severe disease and adverse outcomes, including death [19,20,21,22,23,24,25,26,27].